E Pingchang Chow is a notable inventor based in Charlestown, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments for various diseases. With a focus on interferon beta muteins, his work has the potential to impact the treatment of viral infections and cancer.

Latest Patents

E Pingchang Chow holds 2 patents related to his research on interferon beta muteins. His latest patents include the development of an interferon beta mutein in which phenylalanine (F), tyrosine (Y), tryptophan (W), or histidine (H) is substituted for valine (V) at position 101. These patents also encompass DNA sequences encoding these muteins, recombinant DNA molecules capable of inducing expression of the muteins, and pharmaceutical compositions containing them. The methods outlined in these patents aim to treat viral infections, cancer, tumors, and undesired cell proliferation, as well as for immunomodulation.

Career Highlights

E Pingchang Chow is currently employed at Biogen, Incorporated, where he continues to advance his research in biotechnology. His work has been instrumental in developing new therapeutic approaches that leverage the properties of interferon beta muteins.

Collaborations

Throughout his career, E Pingchang Chow has collaborated with esteemed colleagues, including Susan E Goelz and Richard L Cate. These collaborations have fostered a productive environment for innovation and research in the field.

Conclusion

E Pingchang Chow's contributions to biotechnology, particularly through his patents on interferon beta muteins, highlight his role as a significant inventor in the industry. His work continues to pave the way for new treatments that could benefit many patients worldwide.